Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Interest Expenses (2020 - 2025)

Journey Medical's Interest Expenses history spans 6 years, with the latest figure at $933000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 12.27% year-over-year to $933000.0, compared with a TTM value of $3.7 million through Dec 2025, up 36.96%, and an annual FY2025 reading of $3.7 million, up 36.96% over the prior year.
  • Interest Expenses for Q4 2025 was $933000.0 at Journey Medical, roughly flat from $937000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $4.1 million in Q4 2021, with the low at $24000.0 in Q4 2023.
  • Average Interest Expenses over 5 years is $857450.0, with a median of $703000.0 recorded in 2023.
  • Year-over-year, Interest Expenses crashed 96.11% in 2023 and then soared 3362.5% in 2024.
  • Tracing DERM's Interest Expenses over 5 years: stood at $4.1 million in 2021, then plummeted by 84.94% to $617000.0 in 2022, then crashed by 96.11% to $24000.0 in 2023, then soared by 3362.5% to $831000.0 in 2024, then rose by 12.27% to $933000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Interest Expenses are $933000.0 (Q4 2025), $937000.0 (Q3 2025), and $937000.0 (Q2 2025).